TUMOR BUDDING IN ORAL SQUAMOUS CELL CARCINOMA
Main Article Content
Abstract
Introduction: Tumor budding is a new histopathological marker in several human cancers. Objectives: The aim of this study is to evaluate the grading of tumor budding and its association with the clinico-histopathological features and prognosis of oral squamous cell carcinoma. Methods: A cohort study on 147 cases of oral squamous cell carcinoma treated at the Oncology Hospital in Ho Chi Minh City in 2016 and 2017, examining clinical factors, histopathological grading of malignancy, grading tumor budding, with a five-year survival follow-up. Results: The rates of low, moderate, and high tumor budding in oral cancer were 46.9%, 34.7%, and 18.4%, respectively. Tumor budding was associated with histologic malignancy grade (p<0.001), 5-year overall survival rate (p<0.001), and 5-year overall survival time (p=0.001). Reduced survival prognosis was associated with moderate budding, with an HR of 1.88 (95% CI 1.16–3.05; p=0.01), and high budding, with an HR of 2.56 (95% CI 1.48–3.45; p=0.001). The overall HR for both was 2.09 (95% CI 1.35–3.24; p=0.001). Conclusions: Tumor budding is a potential histopathological factor in the prognosis of oral squamous cell carcinoma. Moderate or high tumor budding is a poor prognostic factor.
Article Details
Keywords
Tumor budding, oral squamous cell carcinoma, histopathology, prognosis.
References
2. Lugli A, et al. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Modern Pathol. 2017;30:1299-1311.
3. Almangush A, et al. Tumour budding in oral squamous cell carcinoma: A meta-analysis. Br J Cancer. 2018;118(4):577-586.
4. Dourado MR, et al. Prognostication for oral squamous cell carcinoma patients based on the tumour–stroma ratio and tumour budding. Histopathol. 2020;76:906-918.
5. Dolens ES, et al. The impact of histopathological features on the prognosis of oral squamous cell carcinoma: A comprehensive review and meta-analysis. Front Oncol. 2021;11:784924.
6. Togni L, et al. The emerging impact of tumor budding in oral squamous cell carcinoma: Main issues and clinical relevance of a new prognostic marker. Cancers. 2022;14:3571.
7. Tan A, Taskin T. Tumor budding should be in oral cavity cancer reporting: A retrospective cohort study based on tumor microenvironment. Cancers. 2022;15:3905-3919.
8. Chiesa‑Estomba CM, et al. Predictive value of tumor budding in head and neck squamous cell carcinoma: An update. Virchows Archiv. 2023;483:441-449.